Target intelligence / Profile preview

Coenzyme A metabolic pathway (CoA metabolic pathway)

Target
CoA metabolic pathway
Molecular classification
Other (metabolic pathway, not a discrete molecular target)
01

Overview

The coenzyme A metabolic pathway encompasses the synthesis, utilization, and degradation of coenzyme A (CoA), a universal and essential cofactor that functions as an acyl group carrier and plays a central role in more than 100 anabolic and catabolic reactions. These include the citric acid cycle, fatty acid synthesis and β-oxidation, amino acid metabolism, cholesterol synthesis, and energy production. CoA metabolism is regulated mainly at the rate-limiting step catalyzed by pantothenate kinase (PANK, with several human isoforms), which senses intracellular CoA levels and adjusts flux accordingly[1][2][3][5][6]. Dysregulation of the pathway is implicated in human diseases such as neurodegenerative disorders, myopathies, cancer, and infection[5][6]. Defects in specific pathway enzymes cause rare metabolic diseases. Because this is a biochemical pathway rather than a single molecular target, it is not a direct therapeutic target, though key pathway enzymes can be targeted for research or drug development.

Other names
CoA biosynthesis pathwayCoenzyme A pathwayCoA metabolismPantothenate-CoA biosynthesis
02

Mechanism of action

Not applicable; pathway not a discrete druggable target, but inhibition or supplementation of pathway enzymes alters CoA levels[5][6]

03

Biological functions

Energy productionMacromolecular biosynthesisLipid metabolismProtein acylation/modificationCellular signalingMetabolism of carbohydrates, fatty acids, amino acids, and xenobiotics[1][2][3][5][6]
04

Disease associations

Neurodegenerative diseaseCancerCardiomyopathyMyopathiesInfection[5][6]
05

Safety considerations

Risks of targeting core metabolic pathways include severe cellular toxicity and multi-organ dysfunction[5][6]Disrupted CoA metabolism may lead to neurodegeneration or muscle/cardiac dysfunction[5][6]
06

Interacting drugs

Pantethine (precursor, used therapeutically for hyperlipidemia[5])

1 more in the full profile.

07

Biomarkers

Cellular/metabolic levels of coenzyme A and its acyl derivativesExpression/activity of key enzymes: Pantothenate kinase (PANK), Coenzyme A synthase (COASY)[5][6]

Beyond the preview

Go deeper on Coenzyme A metabolic pathway (CoA metabolic pathway).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coenzyme A metabolic pathway (CoA metabolic pathway).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call